Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT01245803
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT01245803
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01245803. Randomized; single masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2011-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
- Acronym
- AVATAR
- Condition
- Acute Coronary Syndrome
- Condition
- Angioplasty
- Intervention (Drug)
- additional rosuvastatin loading
- Intervention (Drug)
- placebo control
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct01245803- Content hash
b6afe02a1f038faad766d4ccec8c449b5ebf889b7f627e39142f4df225b9b1ca